During the past decade, UT Southwestern Medical School conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 3 clinical trials were completed, i.e. on average, 150% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "UT Southwestern Medical School" are "Cryptogenic Stroke" (1 trials), "Idiopathic Pulmonary Fibrosis" (1 trials) and "Pulmonary Arterial Hypertension" (1 trials). Many other conditions were trialed in "UT Southwestern Medical School" in a lesser frequency.

Most popular intervention types in "UT Southwestern Medical School" are "Other" (2 trials), "Biological" (1 trials), "Device" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "AMPLATZER PFO Occluder" (1 trials), "PRM-151" (1 trials), "Standard of Care - Medical Management" (1 trials), "placebo" (1 trials) and "sildenafil citrate" (1 trials). Other intervention names were less common.

The vast majority of trials in "UT Southwestern Medical School" are 3 trials for "All" genders.

Currently, there are NaN active trials in "UT Southwestern Medical School". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in UT Southwestern Medical School, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in UT Southwestern Medical School, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".